How does stem cell therapy work for lupus?

Mesenchymal stem cells have demonstrated immunomodulatory effects that may help re-regulate the overactive immune response in systemic lupus erythematosus (SLE). By reducing pro-inflammatory cytokine production and supporting immune tolerance, MSC therapy may help reduce flare frequency and severity for some lupus patients.

Is stem cell therapy safe for lupus patients on immunosuppressant medications?

Stemedix conducts a detailed medication and health review for all autoimmune patients, including those with lupus. Interactions between current immunosuppressants and the treatment protocol are carefully assessed. In some cases, medication adjustments prior to treatment may be recommended in coordination with the patient's rheumatologist.

What lupus symptoms might improve with stem cell therapy?

Patients have reported potential reductions in joint pain, fatigue, skin manifestations, and inflammatory markers following MSC therapy. Kidney and systemic lupus involvement is evaluated on a case-by-case basis, and the treatment is considered adjunctive to — not a replacement for — established lupus disease management.

Lupus

Understanding Lupus

For those seeking to potentially manage symptoms of this condition, Regenerative Medicine for Lupus is a natural alternative option.

Contact a Care Coordinator

What Is Lupus?

Lupus is a chronic autoimmune disease that can affect nearly any organ in the body.
When the immune system, which normally protects against infection, starts attacking healthy tissues, widespread inflammation and tissue damage can occur.

The most common form is Systemic Lupus Erythematosus (SLE).
Because lupus can look different from person to person, symptoms may range from mild fatigue to severe organ involvement.

Common Symptoms Include:

Joint or muscle pain
Fatigue or “flu-like” malaise
Butterfly-shaped rash across the cheeks or nose
Sensitivity to sunlight
Fever, hair loss, or mouth ulcers
In more advanced cases, kidney, heart, lung, or nervous-system inflammation

People often experience flares, periods when symptoms worsen, followed by times of remission when symptoms ease.

Regenerative Medicine For Lupus Discover | Stemedix

The following are potential symptom improvements with Regenerative Medicine:

Improvements in tissue function
Reduction or elimination of dependence on immunosuppressors
Increased energy
Reduction or elimination of low-grade fevers
Reduction or elimination in the appearance of lesions
Potential reduction of antibody levels
Reduction in the damage to vital organs; such as lungs and kidneys

Medical Review: Dr. Gerald Mastaw, MD – Board-Certified Physician Last Updated: October 2025

Recent Clinical Studies of Regenerative Stem Cell Therapy for Lupus

2025 – Double-Blind RCT Using MSC Secretome

Title: Umbilical Cord MSC-Derived Secretome as a Potential Treatment for SLE: A Double-Blind Randomized Controlled Trial
Journal: Stem Cell Research & Therapy – Full Text
Summary:
Twenty-nine women with active lupus received weekly injections of MSC-secretome (the bioactive solution produced by MSCs) or placebo for six weeks.
Patients receiving MSC-secretome had significant reductions in lupus disease activity scores and improved immune markers such as complement C3 and lower inflammatory cytokines (IL-6, TNF-α).
The treatment was safe and well-tolerated, with no severe adverse events.

2025 – Meta-Analysis Across Autoimmune Diseases (Including Lupus)

Title: Efficacy and Safety of MSC Transplantation in Autoimmune and Rheumatic Diseases
Journal: Stem Cell Research & Therapy – Full Text
Summary:
This large review analyzed 42 randomized trials (2,183 patients).
In lupus subgroups, MSC therapy significantly lowered SLE Disease Activity Index (SLEDAI) scores (SMD ≈ –2.32, p=0.0003).
No increase in adverse events was found versus controls.
Researchers concluded MSC therapy is safe and shows measurable improvement in lupus disease activity.

2024 – Phase 1 Dose-Escalation Trial in France

Title: Allogeneic UC-MSC Therapy for Refractory Lupus: A Phase 1 Study
Journal: PubMed Central – Full Text
Summary:
Eight patients with severe, treatment-resistant lupus received escalating doses of UC-MSCs (2–4 million cells/kg).
Treatment was well-tolerated, with only mild transient infusion reactions in two participants.
Over a year of follow-up, disease activity stabilized or improved, supporting safety even at higher doses.

2022 – Phase 1 UC-MSC Trial for Refractory SLE

Title: Safety, Immunologic Effects, and Clinical Response of UC-MSCs in SLE
Journal: Frontiers in Immunology – Full Text
Summary:
Six patients with active lupus unresponsive to medication received a single UC-MSC infusion (1×10⁶ cells/kg).
By 24 weeks, 83% achieved the lupus responder endpoint (SRI-4), showing reduced disease activity and normalization of B-cell profiles.
No serious side effects occurred.
The trial concluded UC-MSC infusion was safe and associated with meaningful clinical improvement.

Regenerative Medicine is still considered an experimental procedure and not approved by the FDA. Patients must consider realistic expectations in their research and possible therapy options.

Could This Be the Right Option for You?

You may wish to explore regenerative options if you:

Have systemic or cutaneous lupus that remains active despite standard therapy
Experience recurrent flares or medication intolerance
Want to learn about immune-modulating, research-based alternatives that may complement current care

At Stemedix, we focus on patient-centered regenerative medicine backed by emerging clinical evidence. Our team reviews your medical history, current treatment, and goals to determine whether regenerative medicine approaches could be a safe adjunctive path forward.

Medical Disclaimer

This page is for educational purposes only and does not constitute medical advice.
Stem cell and secretome-based treatments for lupus are not FDA-approved, and outcomes vary by individual.
Always consult a licensed rheumatologist or qualified healthcare provider before making treatment decisions.

References

Al-Shaer A. et al. Umbilical Cord MSC-Derived Secretome in SLE. Stem Cell Res Ther., 2025. Full Text
Chen Y. et al. MSC Therapy in Autoimmune and Rheumatic Diseases: Meta-Analysis. Stem Cell Res Ther., 2025. Full Text
Dubois M. et al. Allogeneic UC-MSC Treatment for SLE: Phase 1 Trial. PubMed, 2024. Full Text

He L. et al. Safety and Immune Response of UC-MSCs in Refractory SLE. Front Immunol., 2022. Full Text

Speak with a Care Coordinator today for a more accurate assessment of your condition and therapy options.

Speak with a Care Coordinator

Patient Testimonial

Stemedix speaks with Patricia about her experience with Stemedix stem cell treatment for Lupus.

Read Our Reviews

Watch Personal Stories

How Stemedix Helps You Heal

Professional Medical Care

Our Board-Certified Physicians specialize in regenerative medicine. They stay abreast of the latest developments in stem cell research. Each patient is screened and reviewed before being approved for therapy.

Advanced Therapy

Each patient is thoroughly reviewed to ensure their safety for treatment. The physicians will then determine potential benefit candidacy. If approved, a customized treatment plan is offered for the patient.

Specialized Care

Stemedix can help coordinate patients with necessary wheelchair transportation, medical equipment, and Care Giving services as needed during their stay. Your Care Coordinator is available for questions and assistance.

Latest Articles on Regenerative Medicine Therapy for Multiple Sclerosis & Health Awareness

Neurologist discussing brain health research with an adult patient

September 14, 2026

Mesenchymal Stem Cells and Neuroinflammation: Understanding the Role of the Secretome

SCIENTIFIC STUDY REVIEW Featured Article: Mesenchymal stem cells and secretome as modulators of neuroinflammation in neurological disorders Original article: https://link.springer.com/article/10.1186/s12967-026-08052-x Neuroinflammation is the immune response that occurs within the brain and nervous system. In the short term, inflammation can help protect injured tissue and support repair. When it becomes prolonged or poorly regulated, however, it…

Doctor discussing a brain scan with an adult patient

September 9, 2026

Literature Review: Mesenchymal Stem Cell Paracrine Signaling in Neuroinflammation

Reviewed Evidence Reviewed Study 1: Exosomes Derived From Bone Marrow Mesenchymal Stromal Cells Promote Remyelination and Reduce Neuroinflammation in the Demyelinating Central Nervous System Authors: Zhang J, Buller BA, Zhang ZG, et al. Publication & Date: Experimental Neurology. 2022;347:113895. DOI / Link: https://doi.org/10.1016/j.expneurol.2021.113895 | PubMed Reviewed Study 2: Intranasal Delivery of Mesenchymal Stem Cell-Derived Exosomes…

September 1, 2026

Umbilical Cord-Derived MSCs and Immune Thrombocytopenia: Exploring a New Approach to Immune Balance

When the Immune System Targets Platelets Platelets may be tiny, but they play an essential role in helping the blood clot and preventing excessive bleeding. In people with immune thrombocytopenia, or ITP, the immune system mistakenly attacks and destroys platelets faster than the body can replace them. When platelet levels become very low, patients may…

Read all blogs

Forward-Thinking Medicine for Lupus

Contact us today and let Stemedix provide professional service accompanied by one of our Care Coordinators to ensure you have the best experience possible!